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Background
Protein translation is a fundamental biochemical process
and the regulation of this process in response to a vari-
ety of changes has been demonstrated to play a key role
in cellular functional activity. Recently, the translational
control of oncogenes is implicated in many cancers [1].
Results
We recently reported a translation initiation factor eIF4A
RNA helicase-dependent mechanism of translational
control that contributes to oncogenesis and underlies the
anticancer effects of drug silvestrol [2]. Inhibition of
eIF4A with silvestrol has powerful therapeutic effects
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Figure 1 Computational methods revealed drug effects on protein translation. A Histogram of the ratio of TE in control and drug-treated
samples. Red: genes with significant TE down and up regulation were identified based on the read count of Ribo-seq data. Blue and green: TE
up and down genes defined by |Z score| > 2 as often used in other analyses. B Averaged distribution profile of ribosome occupancy of 62 drug-
sensitive genes. Ribosome footprint coverages and transcript lengths were normalized. C Twelve-nucleotide motif that is highly enriched in 5’
UTR of TE down and ROD positive genes. We suggested that the GQ structure is responsible for ribosome stalling in the 5’ UTR [2].
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in vitro and in vivo. In this study, we developed novel
computational tools, specifically be tailored to study high
throughput ribosome footprint data (Ribo-seq) [3], to
identify the genes featuring either one of the two changes
between two experiment conditions: 1) translational effi-
ciency (TE), and 2) ribosome occupancy distribution pro-
file (ROD) on mRNA. In the parametric test of TE, we
take RNA abundance and ribosome occupancy density
into account in order to expeditiously identify differential
translation efficiency. Whereas the non-parametric test
of ROD [4] aims to identify differential occupancy pro-
files, such as ribosome stalling at specific sites even if
overall translation efficiency remain unchanged. Using
transcriptome-scale ribosome footprinting data of leuke-
mia cell line, we defined drug-sensitive genes showing
both decrease of translational efficiency (Figure 1A)
and accumulation of ribosome occupancy at 5’UTR
(Figure 1B). Among the most eIF4A-dependent tran-
scripts are a number of oncogenes, super-enhancer asso-
ciated transcription factors and epigenetic regulators.
Conclusions
Computational and statistical methodologies facilitate
the discovery of the hallmark of eIF4A-dependent tran-
scripts, namely 5’UTR sequence harbors the 12-mer
guanine quartet (CGG)4 motif associated with RNA G-
quadruplex (GQ) structures (Figure 1C). Our novel
computational tools provide a fast, accurate solution to
gain biological insights from Ribo-seq and RNA-seq
data.
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